Back

Liraglutide and empagliflozin – An evaluation of benefits.

27 August 2017 (14:22 - 14:45)
Organised by:
Congress Presentation Part of: Treatment of type 2 diabetes - Important new aspects for the cardiologist Drug therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Associate Professor Thomas Andersen Schmidt

Bispebjerg University Hospital, Copenhagen (Denmark)

3 More presentations in this session

Presentation thumbnail
Treatment aims of glucose lowering drugs in patients with type 2 diabetes
Professor L. Ryden (Stockholm, SE)
Slides Video
Presentation thumbnail
Rethinking the appraisal and approval of drugs for type 2 diabetes.
Professor A. Tsapas (Thessaloniki, GR)
Slides Video
Presentation thumbnail
Is type 2 diabetes a category error - How about treating the elderly?
Professor G. Schernthaner (Vienna, AT)
Slides Video

Access the full session

Session thumbnail
Treatment of type 2 diabetes - Important new aspects for the cardiologist

The Event

Event poster

ESC Congress 2017

27 August 2017 14:22 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources